• TRIPELENNAMINE CITRATE CHEMBL1200769 FDA Approved

    Alternate Names:

    PBZ
    Tripelennamine Citrate
    N'-BENZYL-N,N-DIMETHYL-N'-PYRIDIN-2-YLETHANE-1,2-DIAMINE; 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID
    2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID; N-BENZYL-N-[2-(DIMETHYLAMINO)ETHYL]PYRIDIN-2-AMINE
    1,2-ETHANEDIAMINE, N1,N1-DIMETHYL-N2-(PHENYLMETHYL)-N2-2-PYRIDINYL-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
    3B1-006665
    D06246
    LS-130289
    HE362714
    HE068885
    NCGC00095775-02
    NCGC00018125-05
    NSC-757360
    TOX21_111518_1
    NSC757360
    CCG-39053
    TOX21_111518
    PHARMAKON1600-01500597
    HMS2092A14
    CITRIC ACID; TRIPELENNAMINE
    C16H21N3.C6H8O7
    HMS501K16
    TRIPELENNAMINE CITRATE [USAN]
    SPECTRUM1500597
    TRIPELENNAMINE CITRATE [USP]
    SCHEMBL99166
    PBZ (TN)
    AC1L52TQ
    TRIPELENNAMINECITRATE
    CAS-6138-56-3
    1,2-ETHANEDIAMINE, N,N-DIMETHYL-N'-(PHENYLMETHYL)-N'-2-PYRIDINYL-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
    PYRIDINE, 2-(BENZYL(2-(DIMETHYLAMINO)ETHYL)AMINO)-, CITRATE (1:1)
    2-(BENZYL(2-(DIMETHYLAMINO)ETHYL)AMINO)PYRIDINE CITRATE (1:1)
    DSSTOX_GSID_45989
    DSSTOX_RID_81276
    DSSTOX_CID_25989
    NCGC00095775-01
    EINECS 228-121-6
    30OC46A3J9
    6138-56-3
    UNII-30OC46A3J9
    PYRIBENZAMINE CITRATE
    197066

    Drug Info:

    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Histamine H1 receptor antagonist
    Direct Interaction yes

    Publications: